1. From the Department of Cell Biology and Histology, Academic Medical Center of the University of Amsterdam (AMC-UvA), Amsterdam, the Netherlands; The Netherlands Cancer Institute—Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands; and TeGenero ImmunoTherapeutics AG, Science Park Würzburg, Würzburg, Germany.